The National Cancer Audit Collaborating Centre said prostate, kidney and colon cancers were the worst affected with ...

After Teddi Mellencamp underwent emergency brain surgery for her tumors, the Real Housewives of Beverly Hills star’s sister Justice Mellencamp shared an update on her recovery.

Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030Ramat Gan, Israel, Feb. 18, 2025 (GLOBE ...

There are currently 82,000 incident cases of RCC annually in the United States (account for 3–5% of cancers), with 15,000 deaths annually in the United States. The overall 5-year mortality risk is ~30 ...

Real-world data support trial data on the use of lutetium-177 PSMA-617 in patients with PSMA-positive, metastatic castration-resistant prostate cancer.

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

Radium-223 is an alpha-emitting radiopharmaceutical that accumulates in areas of high bone turnover and has demonstrated a survival benefit in metastatic prostate cancer, 1 but its benefits as a ...